Vactosertib T6496
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Vactosertib is an orally bioavailable inhibitor of the serine/threonine kinase, transforming growth factor (TGF)-beta receptor type 1 (TGFBR1), also known as activin receptor-like kinase 5 (ALK5), with potential antineoplastic activity.
CAS nr:
1352608-82-2
Purity:
98%
Molecular Weight:
399,42
SMILES:
Cc1cccc(n1)-c1[nH]c(CNc2ccccc2F)nc1-c1ccc2ncnn2c1
Formula:
C22H18FN7
Pathway:
Stem Cells,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
TGF-beta/Smad,ALK,ALK
